Clinical Trial Update: Phase I Study of an Oncofetal Antigen Multi-Peptide Immunotherapy in Subjects With Hematologic Cancer [Phase 1]

View source ↗

Summary

A Phase I clinical trial is evaluating an oncofetal antigen multi-peptide immunotherapy in hematologic cancers, including acute myeloid leukemia and multiple my…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Multiple Myeloma
• Myelodysplastic Syndrome
• Smoldering Multiple Myeloma

Drugs mentioned

• Oncofetal antigen multi-peptide immunotherapy

Snippet

Sponsor: Benovus Bio, Inc. | Conditions: Acute Myelogenous Leukemia (AML), Multiple Myeloma (MM) | Phase 1 | Status: UNKNOWN